文献速递呼吸衰竭与机械通气儿科与产科急症重症综合管理与镇静镇痛

儿童重症监护病房毛细支气管炎呼吸支持实践

Respiratory Support Practices for Bronchiolitis in the Pediatric Intensive Care Unit.
PubMed 文献 · JAMA Netw Open · 2024-05-01
一句话结论2013至2022年间,27个PICU中因毛细支气管炎入PICU的例数每年增加350例,与HFNC使用增加242例/年、NIV使用增加126例/年相关,IMV使用无显著变化。

这项横断面研究分析了2013年1月1日至2022年12月31日27个PICU中年龄小于2岁因毛细支气管炎入院的33816例次数据。PICU入院例数每年增加350例(95%CI 170-531),HFNC使用每年增加242例(95%CI 139-345),NIV使用每年增加126例(95%CI 64-189),IMV使用无显著变化(每年10例,95%CI -11至31)。HFNC成功率从2013年的79.8%升至2022年的84.0%(P=.002),NIV成功率从73.2%升至84.0%(P<.001)。较低体重、较高PRISM III评分、心脏病及非急诊科来源与HFNC和NIV失败风险更高相关。作者认为需进一步研究以标准化毛细支气管炎的HFNC和NIV支持方案,减少资源压力。

要点

  • 2013至2022年,27个PICU中毛细支气管炎入院例数每年增加350例(95%CI 170-531),HFNC使用每年增加242例(95%CI 139-345),NIV使用每年增加126例(95%CI 64-189)。
  • IMV使用无显著变化,每年变化10例(95%CI -11至31)。
  • HFNC成功率从2013年79.8%(820/1027)升至2022年84.0%(3693/4399)(P=.002);NIV成功率从73.2%(224/306)升至84.0%(1335/1589)(P<.001)。
  • 较低体重、较高PRISM III评分、心脏病及非急诊科来源与HFNC和NIV失败风险更高相关。
  • 作者认为需进一步研究以标准化毛细支气管炎的HFNC和NIV支持方案,减少资源压力。

适用人群与场景

  • 2013年1月1日至2022年12月31日期间,27个PICU中年龄小于2岁因毛细支气管炎入院的患者,共33816例次;其中男性20186例(59.7%),年龄≤28天1910例(5.6%),29天至<2岁31906例(94.4%)。
  • 15518例患者中7615例(49.1%)有呼吸道合胞病毒感染;33816例次中1522例(4.5%)有心脏病。

诊断标准与关键阈值

  • HFNC成功定义为降级至创伤性更小的支持(室内空气或低流量鼻导管);NIV成功定义为降级至室内空气、低流量鼻导管或HFNC;失败定义为未达到成功标准。

研究设计与关键结果

  • 研究类型为横断面研究,数据来自Virtual Pediatric Systems数据库,涵盖27个PICU,共33816例次毛细支气管炎入院。
  • PICU入院例数每年增加350例(95%CI 170-531)。按所需最大呼吸支持水平分组,HFNC使用每年增加242例(95%CI 139-345),NIV使用每年增加126例(95%CI 64-189),IMV使用无显著变化(每年10例,95%CI -11至31)。
  • HFNC成功22381例(81.8%),重新开始HFNC 431例(1.6%),升级至NIV 3057例(11.2%),升级至IMV或ECMO 1476例(5.4%);HFNC成功率从2013年79.8%(820/1027)升至2022年84.0%(3693/4399)(P=.002)。
  • NIV成功8476例(81.5%),重新开始NIV 787例(7.6%),升级至IMV或ECMO 1135例(10.9%);NIV成功率从2013年73.2%(224/306)升至2022年84.0%(1335/1589)(P<.001)。
  • 多因素logistic回归显示,较低体重、较高PRISM III评分、心脏病及非急诊科来源与HFNC和NIV失败风险更高相关。

证据类型、等级与局限

  • 证据类型为横断面研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为需进一步研究以标准化毛细支气管炎的HFNC和NIV支持方案,以减少资源压力。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Admissions to the pediatric intensive care unit (PICU) due to bronchiolitis are increasing. Whether this increase is associated with changes in noninvasive respiratory support practices is unknown.

OBJECTIVE: To assess whether the number of PICU admissions for bronchiolitis between 2013 and 2022 was associated with changes in the use of high-flow nasal cannula (HFNC), noninvasive ventilation (NIV), and invasive mechanical ventilation (IMV) and to identify factors associated with HFNC and NIV success and failure.

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study examined encounter data from the Virtual Pediatric Systems database on annual PICU admissions for bronchiolitis and ventilation practices among patients aged younger than 2 years admitted to 27 PICUs between January 1, 2013, and December 31, 2022. Use of HFNC and NIV was defined as successful if patients were weaned to less invasive support (room air or low-flow nasal cannula for HFNC; room air, low-flow nasal cannula, or HFNC for NIV).

MAIN OUTCOMES AND MEASURES: The main outcome was the number of PICU admissions for bronchiolitis requiring the use of HFNC, NIV, or IMV. Linear regression was used to analyze the association between admission year and absolute numbers of encounters stratified by the maximum level of respiratory support required. Multivariable logistic regression was used to analyze factors associated with HFNC and NIV success and failure (defined as not meeting the criteria for success).

RESULTS: Included in the analysis were 33 816 encounters for patients with bronchiolitis (20 186 males [59.7%]; 1910 patients [5.6%] aged ≤28 days and 31 906 patients [94.4%] aged 29 days to <2 years) treated at 27 PICUs from 2013 to 2022. A total of 7615 of 15 518 patients (49.1%) had respiratory syncytial virus infection and 1522 of 33 816 (4.5%) had preexisting cardiac disease. Admissions to the PICU increased by 350 (95% CI, 170-531) encounters annually. When data were grouped by the maximum level of respiratory support required, HFNC use increased by 242 (95% CI, 139-345) encounters per year and NIV use increased by 126 (95% CI, 64-189) encounters per year. The use of IMV did not significantly change (10 [95% CI, -11 to 31] encounters per year). In all, 22 381 patients (81.8%) were successfully weaned from HFNC to low-flow oxygen therapy or room air, 431 (1.6%) were restarted on HFNC, 3057 (11.2%) were escalated to NIV, and 1476 (5.4%) were escalated to IMV or extracorporeal membrane oxygenation (ECMO). Successful use of HFNC increased from 820 of 1027 encounters (79.8%) in 2013 to 3693 of 4399 encounters (84.0%) in 2022 (P = .002). In all, 8476 patients (81.5%) were successfully weaned from NIV, 787 (7.6%) were restarted on NIV, and 1135 (10.9%) were escalated to IMV or ECMO. Success with NIV increased from 224 of 306 encounters (73.2%) in 2013 to 1335 of 1589 encounters (84.0%) in 2022 (P < .001). In multivariable logistic regression, lower weight, higher Pediatric Risk of Mortality III score, cardiac disease, and PICU admission from outside the emergency department were associated with greater odds of HFNC and NIV failure.

CONCLUSIONS AND RELEVANCE: Findings of this cross-sectional study of patients aged younger than 2 years admitted for bronchiolitis suggest there was a 3-fold increase in PICU admissions between 2013 and 2022 associated with a 4.8-fold increase in HFNC use and a 5.8-fold increase in NIV use. Further research is needed to standardize approaches to HFNC and NIV support in bronchiolitis to reduce resource strain.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Pelletier JH, Maholtz DE, Hanson CM, et al. Respiratory Support Practices for Bronchiolitis in the Pediatric Intensive Care Unit. JAMA Netw Open. 2024. PMID: 38728028. doi:10.1001/jamanetworkopen.2024.10746

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。